
|Articles|November 26, 2012
Ranbaxy recalls atorvastatin calcium tablets in 10-, 20-, 40-mg dosages
More than 40 lots of atorvastatin calcium tablets, the generic version of Pfizer?s Lipitor, are being recalled by Ranbaxy Pharmaceuticals Inc. (RPI) because they may contain glass particles that are estimated to be less than 1 mm in size, according to Ranbaxy's website.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
The Emergence of CGRP-Targeted Therapies is Transforming Migraine Care | NCPA 2025
2
FDA Approves Tezepelumab for as Add-On Treatment for Chronic Rhinosinusitis With Nasal Polyps
3
Pharmacists Improve Patient Health Through Medication Reviews
4
FDA Approves Oral Semaglutide for Risk of MACE for Patients With Diabetes
5